(Cost-) Effectiveness of a guided internet-based preventive intervention for individuals with chronic pain in the green sector

Conditions

Chronic pain

Lina Braun, Yannik Terhorst, Ingrid Titzler, Johanna Freund, Janika Thielecke et al. (7 authors)

International Journal of Environmental Research and Public Health2022-10-2513 citations

10.3390/ijerph192113858

Barriers to and Facilitators of Engaging With and Adhering to Guided Internet-Based Interventions for Depression Prevention and Reduction of Pain-Related Disability in Green Professions: Mixed Methods Study

Lina Braun, Johanna Freund, Janika Thielecke, Harald Baumeister, David Daniel Ebert et al. (6 authors)

JMIR Mental Health2022-08-0712 citations

10.2196/39122

Clinical and cost-effectiveness of a guided internet-based Acceptance and Commitment Therapy to improve chronic pain–related disability in green professions (PACT-A): study protocol of a pragmatic randomised controlled trial

Yannik Terhorst, Lina Braun, Ingrid Titzler, Claudia Buntrock, Johanna Freund et al. (8 authors)

BMJ Open2020-09-019 citations

10.1136/bmjopen-2019-034271

Interventions

Group 1: Intervention group: The intervention is an online prevention program based on the Acceptance and Commitment Therapy (ACT). The program is structured in seven weekly sessions. In the first s

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: • Agriculturists, foresters and horticulturists with a LAK- or LKK insurance status. The study is accessible for entrepreneurs, collaborating spouses and family members as well as elderly people, who do no longer contribute to the production process (“Altenteiler”) with LAK- or LKK-insurance status • Chronic pain (duration >= 6 months; CPG >= Grade II) • Internet access • Informed consent

Exclusion criteria

Exclusion criteria: • Current psychotherapeutic treatment • Indication for at least subthreshold depression and preference for participation in a parallel clinical study focusing on prevention of depression (PROD-A: https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00014000) • Increased suicidal risk (suicidality items PHQ-9 >=1 & BDI-II >=1 / suicidality items QIDS-SR16 >=1 & BDI-II >=1) and denial to sign a non-suicide contract

Design outcomes

Primary

Measure	Time frame
Primary outcome is pain interference (MPI) 9 weeks after randomization.	—

Secondary

Measure	Time frame
Clinical and cost-effectiveness of internet-based interventions will be evaluated over a period of 36 months (T0 Baseline, T1 Post - 9 weeks, T2 6-month follow-up (FU), T3 12-month FU, T4 24-month FU, T5 36-month FU). Secondary Outcomes: • Pain interference (MPI, BPI): T2-T5 • Pain intensity: T1-T5 • Perceived improvement: T2-T5 • Depressive symptom severity (QIDS-SR16): T1-T5 • Incidence of clinical relevant depressive symptomology (QIDS-SR16 = 11) in subgroup without clinical relevant depression at T0: T1 - T5 • 12 month prevalence of depression (CIDI-SC): T3-T5 • Presence of suicidal ideation (suicidality items PHQ-9, QIDS-SR16, BDI-II): T1 - T5 • Severity of anxiety (GAD-7): T1-T5 • Perceived stress (PSS-10): T1-T5 • Severity of insomnia (ISI): T1-T5 • Chronic pain Acceptance (CPAQ):T1-T5 • Cognitive Defusion (CFQ): T1-T5 • Committed action (CAQ): T1-T5 • Problematic alcohol consumption (AUDIT): T1-T5 • Pain intensity (NRS): T1-T5 • Quality of Life (AQoL-8D): T1-T5 • Negative effects of psychotherapy (INEP): T1-T3 • Therapeutic relationship (WAI-SR, WAI-SRT): T1, T3 • Technologic alliance (TAI-OT): T1-T2 • Subjective prognosis of employment (SPE): T1-T5 • Direct and indirect costs (German adaptation of Trimbos / iMTA questionnaire for costs associated with psychiatric illness (TiC-P) including insurance data about utilization of health care services): T1 - T5 • Patient satisfaction with intervention (CSQ-I): T1	—

Measure

Time frame

Clinical and cost-effectiveness of internet-based interventions will be evaluated over a period of 36 months (T0 Baseline, T1 Post - 9 weeks, T2 6-month follow-up (FU), T3 12-month FU, T4 24-month FU, T5 36-month FU). Secondary Outcomes: • Pain interference (MPI, BPI): T2-T5 • Pain intensity: T1-T5 • Perceived improvement: T2-T5 • Depressive symptom severity (QIDS-SR16): T1-T5 • Incidence of clinical relevant depressive symptomology (QIDS-SR16 = 11) in subgroup without clinical relevant depression at T0: T1 - T5 • 12 month prevalence of depression (CIDI-SC): T3-T5 • Presence of suicidal ideation (suicidality items PHQ-9, QIDS-SR16, BDI-II): T1 - T5 • Severity of anxiety (GAD-7): T1-T5 • Perceived stress (PSS-10): T1-T5 • Severity of insomnia (ISI): T1-T5 • Chronic pain Acceptance (CPAQ):T1-T5 • Cognitive Defusion (CFQ): T1-T5 • Committed action (CAQ): T1-T5 • Problematic alcohol consumption (AUDIT): T1-T5 • Pain intensity (NRS): T1-T5 • Quality of Life (AQoL-8D): T1-T5 • Negative effects of psychotherapy (INEP): T1-T3 • Therapeutic relationship (WAI-SR, WAI-SRT): T1, T3 • Technologic alliance (TAI-OT): T1-T2 • Subjective prognosis of employment (SPE): T1-T5 • Direct and indirect costs (German adaptation of Trimbos / iMTA questionnaire for costs associated with psychiatric illness (TiC-P) including insurance data about utilization of health care services): T1 - T5 • Patient satisfaction with intervention (CSQ-I): T1

—

Countries

Germany

Contacts

Public ContactLina Braun

Universität Ulm, Institut für Psychologie und Pädagogik, Abteilung für Klinische Psychologie und Psychotherapie

lina.braun@uni-ulm.de+49-(0)731/50 328 14

Outcome results

None listed